K183200 is an FDA 510(k) clearance for the iSee (roflufocon D, roflufocon E) Daily Wear Orthokeratology Contact Lenses. Classified as Lens, Contact (orthokeratology) (product code MUW), Class II - Special Controls.
Submitted by C&E GP Specialist, Inc. (San Diego, US). The FDA issued a Cleared decision on January 9, 2019 after a review of 51 days - a notably fast clearance cycle.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5916 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.